ePLAR showed moderate ability to predict elevated pulmonary vascular resistance (≥5 Wood Units) in adults with unrepaired ASD (AUC 0.754), while TR Vmax/RVOT VTI had stronger discrimination (AUC 0.907).
Observational (n=89)
Does ePLAR accurately identify elevated pulmonary vascular resistance in adults with unrepaired atrial septal defect?
ePLAR is a practical non-invasive echocardiographic parameter for identifying elevated pulmonary vascular resistance in adults with unrepaired ASD, though TR Vmax/RVOT VTI may offer superior discrimination.
Effect estimate: AUC 0.754
Absolute Event Rate: 0.41% vs 0.29%
p-value: p=<0.0001
The accurate evaluation of pulmonary vascular resistance (PVR) is critical for evaluating operability and guiding management in adults with unrepaired atrial septal defect (ASD). Non-invasive echocardiographic markers, such as the echocardiographic Pulmonary to Left Atrial Ratio (ePLAR), calculated by dividing the peak tricuspid regurgitation velocity (TR Vmax) by the ratio of the transmitral E-wave to mitral annular e' velocity, may facilitate early risk stratification and reduce reliance on invasive procedures. Eighty-nine adult patients with unrepaired ASD underwent comprehensive echocardiography and right heart catheterization. ePLAR and additional echocardiographic parameters were measured, and their ability to identify elevated PVR (≥5 Wood Units, WU) was assessed through correlation and receiver operating characteristic (ROC) analysis. PVR ≥ 5 group showed elevated ePLAR (0.41 vs. 0.29, p 0.05). ePLAR is a practical, novel non-invasive echocardiographic parameter for identifying elevated pulmonary vascular resistance in adults with unrepaired ASD. With high sensitivity and independent predictive value, ePLAR is suitable for initial screening and risk stratification, potentially reducing unnecessary invasive testing and improving clinical decision-making.
Shabrina et al. (Mon,) conducted a observational in Unrepaired atrial septal defect (ASD) (n=89). Echocardiographic Pulmonary to Left Atrial Ratio (ePLAR) vs. Right heart catheterization was evaluated on Elevated pulmonary vascular resistance (≥5 Wood Units) (AUC 0.754, p=<0.0001). ePLAR showed moderate ability to predict elevated pulmonary vascular resistance (≥5 Wood Units) in adults with unrepaired ASD (AUC 0.754), while TR Vmax/RVOT VTI had stronger discrimination (AUC 0.907).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: